Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — Shareholder Meeting (April 2025)
14 slides from Trendlines's shareholder meeting presentation, April 2025
Slide 1: Succeeding Together
Succeeding Together Transforming futures in medtech & agrifood Haim Brosh, Executive Director & CEO April 2025
Slide 2: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 3: FY 2024: Key Points
FY 2024: Key Points • A record ~US$42 million in external funding • A net loss of US$10.2 million • Misappropriation of funds at US$2.1 million for FY 2023 and FY 2024 • US$8.5 million increase in Non IFRS value • Significant operating costs reduction, excluding TMS & misappropriated funds 3
Slide 4: FY 2024 financials
FY 2024 “= trendlines
Slide 5: Balance sheet: Assets
Balance sheet. Assets ASSETS CURRENT ASSETS: Cash and cash equivalents Short-term bank deposits Accounts and other receivables Short-term loans to Portfolio Companies Total Current Assets NON-CURRENT ASSETS: Investments in Portfolio Companies Accounts and other receivables Right-of-use assets Invest
Slide 6: Balance sheet: Liabilities & Equity
Balance sheet Liabilities & Equity Group 2024 2023 $’000 $’000 EQUITY: Equity Attributable to Equity LIABILITIES AND EQUITY Holders of the Company: Share capital 2,959 2,605 CURRENT LIABILITIES: Share premium 99,370 93,815 Lease liabilities Reserve from transaction with Loans non-controlling interes
Slide 7: Income Statement
Income Statement 2024 2023 Income: $’000 $’000 Loss from change in fair value of investments in Portfolio Companies, net (3,126) (27,032) Income from services to Portfolio Companies 1,494 3,215 Income from contracted R&D services 225 1,281 Financial income other 514 1,247 Other income 398 362 Total
Slide 8: Misappropriation of Funds
Misappropriation of Funds • Independent Investigation Conducted • Scope and Amount of Misappropriation • Internal Audit Focus Areas • Termination and Legal Actions • Interim Leadership and Recruitment • Internal Control Enhancements • Board Acceptance and Implementation 8
Slide 9: Operations comparison
Operations comparison 2022 2023 Year on 2024 Year on 2025 Year on year % year % year % Change Change Change USD Actual Actual Actual Budget Total operations (9,188)* (7,976)* -13% (4,811)* -40% (3,997) -17% Total investments (6,450) (4,059) (1,976) (2,000) Total for the year (15,638) (12,034) (6,787
Slide 10: A taste of our portfolio companies
A taste of our portfolio 43 companies * portfolio 14 29 agrifood medtech * including the 8 consolidated portfolio companies in Singapore 10
Slide 11: Portfolio cluster values
Portfolio cluster values Non-IFRS* Value of Non-IFRS* Value of Fair Value of Fair Value of Trendlines’ Trendlines’ Share Cluster Share (US$'000) Trendlines’ Share (additional Trendlines’ Share (additional information) information) (US$'000) (US$'000) (US$'000) 31.12.2024 31.12.2023 Aquaculture & Ani
Slide 12: Investment in Portfolio Companies – record year
Investment in Portfolio Companies – record year 12
Slide 13: Thank You
THANK YOU Haim Brosh, Executive Director & CEO - haim@trendlines.com | +972.72.260.7000 | www.trendlines.com
Slide 14: Notes and Disclaimer
Notes and Disclaimer The non-IFRS fair value information does not represent any forecast or future performance but serves as an extra aid in evaluating our portfolio companies and investment approaches. The additional information (Non-IFRS value) which, as stated, differs from the IFRS fair value at
The Trendlines Group — Shareholder Meeting (April 2025) on 6ix